Why the study?
Do angiotensin converting enzyme (ACE) inhibitors prevent clinical heart failure and adverse outcomes in patients with asymptomatic left ventricular systolic dysfunction?
Do angiotensin converting enzyme (ACE) inhibitors prevent clinical heart failure and adverse outcomes in patients with asymptomatic left ventricular systolic dysfunction?
ACE inhibitor treatment offers substantial benefit for patients with asymptomatic LV systolic dysfunction by preventing progression to clinical heart failure and reducing hospitalizations.
No takes yet. Share an insight, caveat, or question.
Supports ACE inhibitor use in asymptomatic LV systolic dysfunction; confirms benefits across endpoints but leaves open need for updated randomized data.
Marvin A. Konstam (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: